Effect of fecal immunochemical test cut-off levels on adenoma detection rate: a systematic review and meta-analysis

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249.
   PubMed Web of Science ®Google Scholar
• Levi Z, Birkenfeld S, Vilkin A, et al. A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study. Int J Cancer. 2011;128:2415–2424.
   PubMed Web of Science ®Google Scholar
• Benard F, Barkun AN, Martel M, et al. Systematic review of colorectal cancer screening guidelines for average-risk adults: summarizing the current global recommendations. World J Gastroenterol. 2018;24:124–138.
   PubMed Web of Science ®Google Scholar
• Chiu HM, Chen SL, Yen AM, et al. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the one million Taiwanese screening program. Cancer. 2015;121(18):3221–3229. doi: 10.1002/cncr.29462.
   PubMed Web of Science ®Google Scholar
• Ebell MH. FIT more acceptable with better detection rate than gFOBT for colorectal cancer screening. Am Fam Physician. 2018;97(12):818.
   PubMed Web of Science ®Google Scholar
• Rabeneck L, Rumble RB, Thompson F, et al. Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening. Can J Gastroenterol. 2012;26:131–147.
   PubMed Web of Science ®Google Scholar
• van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135(1):82–90. doi: 10.1053/j.gastro.2008.03.040.
   PubMed Web of Science ®Google Scholar
• Shapiro JA, Bobo JK, Church TR, et al. A comparison of fecal immunochemical and high-sensitivity guaiac tests for colorectal cancer screening. Am J Gastroenterol. 2017;112(11):1728–1735. doi: 10.1038/ajg.2017.285.
   PubMed Web of Science ®Google Scholar
• Hitchcock ME. Translating the adenoma detection rate as a quality measure for endoscopists to a public health approach to screening underserved patients for colorectal cancer. Gastroenterology. 2022;162(3):702–704. doi: 10.1053/j.gastro.2021.11.013.
   PubMed Web of Science ®Google Scholar
• Kaminski MF, Wieszczy P, Rupinski M, et al. Increased rate of adenoma detection associates with reduced risk of colorectal cancer and death. Gastroenterology. 2017;153(1):98–105. doi: 10.1053/j.gastro.2017.04.006.
   PubMed Web of Science ®Google Scholar
• Kaminski MF, Regula J, Kraszewska E, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010;362(19):1795–1803. doi: 10.1056/NEJMoa0907667.
   PubMed Web of Science ®Google Scholar
• Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society task force on colorectal cancer. Gastroenterology. 2017;153(1):307–323. doi: 10.1053/j.gastro.2017.05.013.
   PubMed Web of Science ®Google Scholar
• Mohan BP, Khan SR, Daugherty E, et al. Pooled rates of adenoma detection by colonoscopy in asymptomatic average-risk individuals with positive fecal immunochemical test: a systematic review and meta-analysis. Gastrointest Endosc. 2022;96:208–222.
   PubMed Web of Science ®Google Scholar
• Canadian Partnership Against Cancer. Colorectal cancer screening in Canada: environmental scan. Toronto: Canadian Partnership Against Cancer; 2018.
   Google Scholar
• Kooyker AI, Toes-Zoutendijk E, Opstal-van Winden AWJ, et al. The second round of the dutch colorectal cancer screening program: impact of an increased fecal immunochemical test cut-off level on yield of screening. Int J Cancer. 2020;147(4):1098–1106.
   PubMed Web of Science ®Google Scholar
• McGowan J, Sampson M, Salzwedel DM, et al. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40–46. doi: 10.1016/j.jclinepi.2016.01.021.
   PubMed Web of Science ®Google Scholar
• The National Heart, Lung, and Blood Institute. Study quality ­assessment tools; 2021 [updated 2021 July, cited 2022 Jun 25]. Available from: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools.
   Google Scholar
• Ko CW, Dominitz JA, Nguyen TD. Fecal occult blood testing in a general medical clinic: comparison between guaiac-based and immunochemical-based tests. Am J Med. 2003;115(2):111–114. doi: 10.1016/s0002-9343(03)00294-8.
   PubMed Web of Science ®Google Scholar
• Lin L, Xu C. Arcsine-based transformations for meta-analysis of proportions: pros, cons, and alternatives. Health Sci Rep. 2020;3(3):E178. doi: 10.1002/hsr2.178.
   PubMedGoogle Scholar
• Launoy GD, Bertrand HJ, Berchi C, et al. Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population. Int J Cancer. 2005;115:493–496.
   PubMed Web of Science ®Google Scholar
• Allison JE, Sakoda LC, Levin TR, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst. 2007;99:1462–1470.
   PubMedGoogle Scholar
• Guittet L, Bouvier V, Mariotte N, et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut. 2007;56(2):210–214. doi: 10.1136/gut.2006.101428.
   PubMed Web of Science ®Google Scholar
• Dancourt V, Lejeune C, Lepage C, et al. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms. Eur J Cancer. 2008;44(15):2254–2258. doi: 10.1016/j.ejca.2008.06.041.
   PubMed Web of Science ®Google Scholar
• Parente F, Marino B, DeVecchi N, et al. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer. Br J Surg. 2009;96(5):533–540. doi: 10.1002/bjs.6568.
   PubMed Web of Science ®Google Scholar
• Hol L, Wilschut JA, van Ballegooijen M, et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer. 2009;100(7):1103–1110. doi: 10.1038/sj.bjc.6604961.
   PubMed Web of Science ®Google Scholar
• Hol L, van Leerdam ME, van Ballegooijen M, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut. 2010;59(1):62–68. doi: 10.1136/gut.2009.177089.
   PubMed Web of Science ®Google Scholar
• Parra-Blanco A, Gimeno-García AZ, Quintero E, et al. Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening. J Gastroenterol. 2010;45(7):703–712. doi: 10.1007/s00535-010-0214-8.
   PubMed Web of Science ®Google Scholar
• Crotta S, Segnan N, Paganin S, et al. High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test. Clin Gastroenterol Hepatol. 2012;10(6):633–638. doi: 10.1016/j.cgh.2012.02.030.
   PubMed Web of Science ®Google Scholar
• Denters MJ, Deutekom M, Bossuyt PM, et al. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer. Gastroenterology. 2012;142(3):497–504. doi: 10.1053/j.gastro.2011.11.024.
   PubMed Web of Science ®Google Scholar
• de Wijkerslooth TR, Stoop EM, Bossuyt PM, et al. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am J Gastroenterol. 2012;107(10):1570–1578. doi: 10.1038/ajg.2012.249.
   PubMed Web of Science ®Google Scholar
• Faivre J, Dancourt V, Manfredi S, et al. Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programme. Dig Liver Dis. 2012;44(8):700–704. doi: 10.1016/j.dld.2012.03.015.
   PubMedGoogle Scholar
• Quintero E, Castells A, Bujanda L, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012;366(8):697–706. doi: 10.1056/NEJMoa1108895.
   PubMed Web of Science ®Google Scholar
• Kelley L, Swan N, Hughes DJ. An analysis of the duplicate testing strategy of an irish immunochemical faecal occult blood test colorectal cancer screening programme. Colorectal Dis. 2013;15(9):E512–21. doi: 10.1111/codi.12310.
   PubMed Web of Science ®Google Scholar
• Major D, Bryant H, Delaney M, et al. Colorectal cancer screening in Canada: results from the first round of screening for five provincial programs. Curr Oncol. 2013;20:252–257.
   PubMed Web of Science ®Google Scholar
• Raginel T, Puvinel J, Ferrand O, et al. A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening. Gastroenterology. 2013;144(5):918–925. doi: 10.1053/j.gastro.2013.01.042.
   PubMed Web of Science ®Google Scholar
• Chiang TH, Chuang SL, Chen SL, et al. Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program. Gastroenterology. 2014;147(6):1317–1326. doi: 10.1053/j.gastro.2014.08.043.
   PubMed Web of Science ®Google Scholar
• Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370(14):1287–1297. doi: 10.1056/NEJMoa1311194.
   PubMed Web of Science ®Google Scholar
• Leen R, Seng-Lee C, Holleran G, et al. Comparison of faecal M2-PK and FIT in a population-based bowel cancer screening cohort. Eur J Gastroenterol Hepatol. 2014;26(5):514–518. doi: 10.1097/MEG.0000000000000025.
   PubMed Web of Science ®Google Scholar
• Stegeman I, van Doorn SC, Mundt MW, et al. Participation, yield, and interval carcinomas in three rounds of biennial FIT-based colorectal cancer screening. Cancer Epidemiol. 2015;39:388–393.
   PubMed Web of Science ®Google Scholar
• Zorzi M, Senore C, Da Re F, et al. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (evaluating quality indicators of the performance of endoscopy). Gut. 2015;64(9):1389–1396. doi: 10.1136/gutjnl-2014-307954.
   PubMed Web of Science ®Google Scholar
• Alvarez-Urturi C, Andreu M, Hernandez C, et al. Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening. Dig Liver Dis. 2016;48:542–551.
   PubMedGoogle Scholar
• Caviglia GP, Cabianca L, Fagoonee S, et al. Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin vs. fecal M2-type pyruvate kinase. Biochem Med. 2016;26(1):114–120. doi: 10.11613/BM.2016.012.
   PubMed Web of Science ®Google Scholar
• Cubiella J, Castells A, Andreu M, et al. Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs. United European Gastroenterol J. 2017;5:255–260.
   PubMed Web of Science ®Google Scholar
• Hassan C, Senore C, Radaelli F, et al. Full-spectrum (FUSE) versus standard forward-viewing colonoscopy in an organised colorectal cancer screening programme. Gut. 2017;66:1949–1955.
   PubMed Web of Science ®Google Scholar
• Hilsden RJ, Bridges R, Dube C, et al. Defining benchmarks for adenoma detection rate and adenomas per colonoscopy in patients undergoing colonoscopy due to a positive fecal immunochemical test. Am J Gastroenterol. 2016;111(12):1743–1749. doi: 10.1038/ajg.2016.449.
   PubMed Web of Science ®Google Scholar
• Jensen CD, Corley DA, Quinn VP, et al. Fecal immunochemical test program performance over 4 rounds of annual screening: a retrospective cohort study. Ann Intern Med. 2016;164(7):456–463. doi: 10.7326/M15-0983.
   PubMed Web of Science ®Google Scholar
• Passamonti B, Malaspina M, Fraser CG, et al. A comparative effectiveness trial of two faecal immunochemical tests for haemoglobin (FIT). Assessment of test performance and adherence in a single round of a population-based screening programme for colorectal cancer. Gut. 2018;67(3):485–496. doi: 10.1136/gutjnl-2016-312716.
   PubMed Web of Science ®Google Scholar
• Sali L, Mascalchi M, Falchini M, et al. Reduced and full-preparation CT colonography, fecal immunochemical test, and colonoscopy for population screening of colorectal cancer: a randomized trial. J Natl Cancer Inst. 2015;108:dvj319.
   Google Scholar
• Shahidi N, Gentile L, Gondara L, et al. Correlating quantitative fecal immunochemical test results with neoplastic findings on colonoscopy in a population-based colorectal cancer screening program: a prospective study. Can J Gastroenterol Hepatol. 2016;2016:465–471.
   Web of Science ®Google Scholar
• Akram A, Juang D, Bustamante R, et al. Replacing the guaiac fecal occult blood test with the fecal immunochemical test increases proportion of individuals screened in a large healthcare setting. Clin Gastroenterol Hepatol. 2017;15:1265–1270.
   PubMed Web of Science ®Google Scholar
• Chang LC, Shun CT, Hsu WF, et al. Fecal immunochemical test detects sessile serrated adenomas and polyps with a low level of sensitivity. Clin Gastroenterol Hepatol. 2017;15:872–879.
   PubMed Web of Science ®Google Scholar
• Chiu SY, Chuang SL, Chen SL, et al. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese nationwide colorectal cancer screening program. Gut. 2017;66(2):293–300. doi: 10.1136/gutjnl-2015-310256.
   PubMed Web of Science ®Google Scholar
• Kapidzic A, van Roon AH, van Leerdam ME, et al. Attendance and diagnostic yield of repeated two-sample faecal immunochemical test screening for colorectal cancer. Gut. 2017;66(1):118–123. doi: 10.1136/gutjnl-2014-308957.
   PubMed Web of Science ®Google Scholar
• Singal AG, Gupta S, Skinner CS, et al. Effect of colonoscopy outreach vs fecal immunochemical test outreach on colorectal cancer screening completion: a randomized clinical trial. JAMA. 2017;318(9):806–815. doi: 10.1001/jama.2017.11389.
   PubMed Web of Science ®Google Scholar
• Tepeš B, Bracko M, Novak Mlakar D, et al. Results of the FIT-based national colorectal cancer screening program in Slovenia. J Clin Gastroenterol. 2017;51(6):E52–e59. doi: 10.1097/MCG.0000000000000662.
   PubMed Web of Science ®Google Scholar
• Kim DH, Cha JM, Kwak MS, et al. Quality metrics of a fecal immunochemical test-based colorectal cancer screening program in Korea. Gut Liver. 2018;12:183–189.
   PubMed Web of Science ®Google Scholar
• Kligman E, Li W, Eckert GJ, et al. Adenoma detection rate in asymptomatic patients with positive fecal immunochemical tests. Dig Dis Sci. 2018;63(5):1167–1172. doi: 10.1007/s10620-018-4984-9.
   PubMed Web of Science ®Google Scholar
• Zorzi M, Hassan C, Capodaglio G, et al. Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test. Gut. 2018;67(12):2124–2130. doi: 10.1136/gutjnl-2017-314753.
   PubMed Web of Science ®Google Scholar
• Bretagne JF, Piette C, Cosson M, et al. Switching from guaiac to immunochemical faecal occult blood test increases participation and diagnostic yield of colorectal cancer screening. Dig Liver Dis. 2019;51(10):1461–1469. doi: 10.1016/j.dld.2019.05.004.
   PubMedGoogle Scholar
• Lund M, Erichsen R, Valori R, et al. Data quality and colonoscopy performance indicators in the prevalent round of a FIT-based colorectal cancer screening program. Scand J Gastroenterol. 2019;54:471–477.
   PubMed Web of Science ®Google Scholar
• Ribbing Wilén H, Blom J, Höijer J, et al. Fecal immunochemical test in colorectal cancer screening: colonoscopy findings by different cut-off levels. J Gastroenterol Hepatol. 2019;34:103–112.
   PubMed Web of Science ®Google Scholar
• Vitellius C, Laly M, Banaszuk AS, et al. Contribution of the OC sensor® immunoassay in comparison to the hemoccult II® guaiac-test in organized colorectal cancer screening. Eur J Epidemiol. 2019;34(2):163–172. doi: 10.1007/s10654-018-0471-z.
   PubMed Web of Science ®Google Scholar
• Wong JCT, Chiu HM, Kim HS, et al. Adenoma detection rates in colonoscopies for positive fecal immunochemical tests versus direct screening colonoscopies. Gastrointest Endosc. 2019;89:607–613.
   PubMed Web of Science ®Google Scholar
• Baldacchini F, Bucchi L, Giuliani O, et al. Results of compliant participation in five rounds of fecal immunochemical test screening for colorectal cancer. Clin Gastroenterol Hepatol. 2021;19:2361–2369.
   PubMed Web of Science ®Google Scholar
• Cariou M, El Fettouhi A, Kermarrec T, et al. Comparative evaluation of two colorectal cancer screening campaigns using different faecal occult blood tests in a French area. Cancer Epidemiol. 2020;69:101839.
   PubMed Web of Science ®Google Scholar
• Chen H, Lu M, Liu C, et al. Comparative evaluation of participation and diagnostic yield of colonoscopy vs fecal immunochemical test vs risk-adapted screening in colorectal cancer screening: interim analysis of a multicenter randomized controlled trial (TARGET-C). Am J Gastroenterol. 2020;115(8):1264–1274. doi: 10.14309/ajg.0000000000000624.
   PubMed Web of Science ®Google Scholar
• Constantin A, Cazacu I, Ciocârlan M, et al. Short term outcomes of using fecal immunochemical test for a pilot colorectal cancer screening program. A single center study on 3024 consecutive patients. Chirurgia. 2020;115(4):448–457. doi: 10.21614/chirurgia.115.4.448.
   PubMed Web of Science ®Google Scholar
• Denis B, Gendre I, Tuzin N, et al. Adenoma detection rate in fecal immunochemical test positive colonoscopies: a population-based observational study. medRxiv; 2020 [cited 2022 Jun 20]. Available from: 10.1101/2020.08.31.20185124v1.
   Google Scholar
• Guo F, De Brabander I, Francart J, et al. Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia-Brussels colorectal cancer screening programme. Br J Cancer. 2020;122(7):1109–1117. doi: 10.1038/s41416-020-0754-5.
   PubMed Web of Science ®Google Scholar
• Levin TR, Jensen CD, Chawla NM, et al. Early screening of African Americans (45–50 years old) in a fecal immunochemical test-based colorectal cancer screening program. Gastroenterology. 2020;159(5):1695–1704.e1. doi: 10.1053/j.gastro.2020.07.011.
   PubMed Web of Science ®Google Scholar
• Sultanian R, Du L, Moysey B, et al. The impact of transitioning from guaiac-fecal occult blood testing to fecal immunochemical testing in a Canadian colon cancer screening program. J Can Assoc Gastroenterol. 2020;3(4):177–184. doi: 10.1093/jcag/gwz009.
   PubMedGoogle Scholar
• Guimarães DP, Mantuan LA, de Oliveira MA, et al. The performance of colorectal cancer screening in Brazil: the first two years of the implementation program in Barretos Cancer Hospital. Cancer Prev Res. 2021;14(2):241–252. doi: 10.1158/1940-6207.CAPR-20-0179.
   PubMed Web of Science ®Google Scholar
• Denis B, Gendre I, Tuzin N, et al. Adenoma detection rate is enough to assess endoscopist performance: a population-based observational study of FIT-positive colonoscopies. Endosc Int Open. 2022;10(9):E1208–E1217. doi: 10.1055/a-1859-8277.
   PubMedGoogle Scholar
• Randel KR, Schult AL, Botteri E, et al. Colorectal cancer screening with repeated fecal immunochemical test versus sigmoidoscopy: baseline results from a randomized trial. Gastroenterology. 2021;160(4):1085–1096.e5. doi: 10.1053/j.gastro.2020.11.037.
   PubMed Web of Science ®Google Scholar
• Wernly S, Wernly B, Semmler G, et al. A sex-specific propensity-adjusted analysis of colonic adenoma detection rates in a screening cohort. Sci Rep. 2021;11(1):17785. doi: 10.1038/s41598-021-97163-0.
   PubMed Web of Science ®Google Scholar
• Wong MCS, Huang J, Huang JLW, et al. Global prevalence of colorectal neoplasia: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2020;18:553–561.
   PubMed Web of Science ®Google Scholar
• Obuch JC, Pigott CM, Ahnen DJ. Sessile serrated polyps: detection, eradication, and prevention of the evil twin. Curr Treat Options Gastroenterol. 2015;13(1):156–170. doi: 10.1007/s11938-015-0046-y.
   PubMedGoogle Scholar
• Forbes N, Hilsden RJ, Martel M, et al. Association between time to colonoscopy after positive fecal testing and colorectal cancer outcomes: a systematic review. Clin Gastroenterol Hepatol. 2021;19:1344–1354.
   PubMed Web of Science ®Google Scholar
• Desai M, Anderson JC, Kaminski M, et al. Sessile serrated lesion detection rates during average risk screening colonoscopy: a systematic review and meta-analysis of the published literature. Endosc Int Open. 2021;9(4):E610–E620. doi: 10.1055/a-1352-4095.
   PubMedGoogle Scholar